Angelo Gordon & Co’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-33,200
Closed -$3.48M 96
2020
Q2
$3.48M Buy
+33,200
New +$3.56M 0.48% 39

Other funds holding BSX.PRA

Angelo Gordon & Co's BSX.PRA Position: Q3 2020 in Review

Angelo Gordon & Co sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2020, closing a stake of 33,200 shares — an estimated $3.48M sold.

Angelo Gordon & Co first reported a position in BSX.PRA in Q2 2020 and held it in 1 quarter. The position peaked at $3.48M in Q2 2020. 43 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2020.

  • Angelo Gordon & Co reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2020 after selling out during the quarter.
  • Angelo Gordon & Co sold 33,200 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2020, an estimated $3.48M.
  • Angelo Gordon & Co first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 1 quarter.
  • Angelo Gordon & Co's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $3.48M in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2020.

Based on Angelo Gordon & Co's 13F filing for Q3 2020, filed 16 Nov 2020.